// App-Quantinova.ai

128 : Comprehensive molecular characterization of 412 muscle-invasive urothelial bladder carcinomas: final analysis of The Cancer Genome Atlas (TCGA) project

Researchers

Presenter

  • John N. Weinstein

Principal Investigators

  • David J. Kwiatkowski

  • Gad Getz

  • Jaegil Kim

  • Hikmat A. Al-ahmadie

  • Andrew D. Cherniack

  • Guangwu Guo

  • Rehan Akbani

  • Katherine A. Hoadley

  • William Y. Kim

  • Gordon Robertson

  • Andrew J. Mungall

  • Toshinori Hinoue

  • Peter W. Laird

  • Jonathan E. Rosenberg

  • Joaquim Bellmunt

  • Dean F. Bajorin

  • Margaret B. Morgan

  • Chad J. Creighton

  • Dmitry Gordenin

  • Joshua M. Stuart

  • Xiaoping Su

  • Michael C. Ryan

  • Jeffrey S. Damrauer

  • Wei Zhang

  • Yuexin Liu

  • Yiling Lu

  • Nikolaus Schultz

  • Raju Kucherlapati

  • Gordon B. Mills

  • Donna E. Hansel

  • Brian D. Robinson

  • Bodgen A. Czerniak

  • Victor E. Reuter

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Baylor College of Medicine, Houston, TX

  • Brigham and Women's Hospital, Brookline, MA

  • Broad Institute of Massachusetts Institute of Technology and Harvard University Cambridge, Boston, MA

  • Broad Institute of Massachusetts Institute of Technology and Harvard University Cambridge, Boston, MA

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Lineberger Comprehensive Cancer Center at the University of North Carolina, Chapel Hill, NC

  • BC Cancer Agency, Vancouver, British Columbia, Canada.

  • University of Southern California Epigenome Center, Los Angeles, CA

  • Mechanisms of Genome Dynamics Group, Research Trianble Park, NC

  • University of California, Santa Cruz, Santa Cruz, CA

  • In Silico Solutions,, Fairfax, VA

  • University of North Carolina, Chapel Hill, NC

  • Harvard Medical School, Boston, MA

  • University of California-San Diego, San Diego, CA

  • Weill Cornell Medical College of Cornell University, New York, NY

Locations

  • United States

  • Canada

Companies

  • In Silico Solutions,

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

  • Solid malignancies

Biomarkers

  • DNA methylation

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved